Build Your Comparison

Side-by-side financial analysis
SCHW logo
SCHW
MS logo
MS
Try popular comparisons:

Stock Comparison

SCHW vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals30-year financialsFull price history
SCHW
The Charles Schwab Corporation

Investment Banks & Brokerages

Financial ServicesNYSE • US
Market Cap$159.11B
5Y Perf.+87.6%
MS
Morgan Stanley

Investment Banks & Brokerages

Financial ServicesNYSE • US
Market Cap$286.18B
5Y Perf.+193.4%

SCHW vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SCHW logoSCHW
MS logoMS
IndustryInvestment Banks & BrokeragesInvestment Banks & Brokerages
Market Cap$159.11B$286.18B
Revenue (TTM)$27.89B$74.76B
Net Income (TTM)$10.64B$19.55B
Gross Margin97.0%99.6%
Operating Margin49.5%33.8%
Forward P/E14.2x14.1x
Total Debt$30.95B$475.56B
Cash & Equiv.$46.03B$111.69B

SCHW vs MS — Long-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SCHW
MS
StockNov 20Nov 26Return
The Charles Schwab … (SCHW)100187.6+87.6%
Morgan Stanley (MS)100293.4+193.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SCHW vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SCHW leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Morgan Stanley is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
🥇SCHW emerged as the overall leader. Track its performance:
SCHW
The Charles Schwab Corporation
The Banking Pick

SCHW carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 22.0%, EPS growth 55.9%, 3Y rev CAGR 4.8%
  • Lower volatility, beta 0.45, Low D/E 62.6%, current ratio 0.53x
  • PEG 0.83 vs MS's 1.47
Best for: growth exposure and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 1.46, yield 2.3%
  • 5.2% 10Y total return vs SCHW's 207.5%
  • Beta 1.46, yield 2.3%, current ratio 1.17x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSCHW logoSCHW22.0% NII/revenue growth vs MS's 14.5%
ValueMS logoMSLower P/E (14.1x vs 14.2x)
Quality / MarginsSCHW logoSCHWEfficiency ratio 0.5% vs MS's 0.7% (lower = leaner)
Stability / SafetySCHW logoSCHWBeta 0.45 vs MS's 1.46, lower leverage
DividendsMS logoMS2.3% yield, 12-year raise streak, vs SCHW's 1.4%
Momentum (1Y)MS logoMS+13.7% vs SCHW's -1.6%
Efficiency (ROA)SCHW logoSCHWEfficiency ratio 0.5% vs MS's 0.7%

SCHW vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SCHWThe Charles Schwab Corporation
FY 2025
Investor Services
79.4%$19.0B
Advisor Services
20.6%$4.9B
MSMorgan Stanley
FY 2025
Institutional Securities Segment
46.4%$33.1B
Wealth Management Segment
44.5%$31.8B
Investment Management Segment
9.1%$6.5B

SCHW vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSCHWLAGGINGMS

Income & Cash Flow (Last 12 Months)

SCHW leads this category, winning 4 of 6 comparable metrics.

MS is the larger business by revenue, generating $74.8B annually — 2.7x SCHW's $27.9B. SCHW is the more profitable business, keeping 38.2% of every revenue dollar as net income compared to MS's 26.2%. On growth, MS holds the edge at +30.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
RevenueTrailing 12 months$27.9B$74.8B
EBITDAEarnings before interest/tax$15.2B$28.5B
Net IncomeAfter-tax profit$10.6B$19.6B
Free Cash FlowCash after capex$3.3B-$12.1B
Gross MarginGross profit ÷ Revenue+97.0%+99.6%
Operating MarginEBIT ÷ Revenue+49.5%+33.8%
Net MarginNet income ÷ Revenue+38.2%+26.2%
FCF MarginFCF ÷ Revenue+11.9%-16.2%
Rev. Growth (YoY)Latest quarter vs prior year+16.9%+30.3%
EPS Growth (YoY)Latest quarter vs prior year+28.6%+8.2%
SCHW leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MS leads this category, winning 5 of 7 comparable metrics.

At 17.8x trailing earnings, MS trades at a 9% valuation discount to SCHW's 19.6x P/E. Adjusting for growth (PEG ratio), SCHW offers better value at 1.15x vs MS's 1.86x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
Market CapShares × price$159.1B$286.2B
Enterprise ValueMkt cap + debt − cash$144.0B$650.0B
Trailing P/EPrice ÷ TTM EPS19.63x17.79x
Forward P/EPrice ÷ next-FY EPS est.14.16x14.07x
PEG RatioP/E ÷ EPS growth rate1.15x1.86x
EV / EBITDAEnterprise value multiple11.23x24.43x
Price / SalesMarket cap ÷ Revenue6.65x4.34x
Price / BookPrice ÷ Book value/share3.29x2.57x
Price / FCFMarket cap ÷ FCF18.16x6.21x
MS leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

SCHW leads this category, winning 9 of 9 comparable metrics.

SCHW delivers a 21.3% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $17 for MS. SCHW carries lower financial leverage with a 0.63x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 4.22x. On the Piotroski fundamental quality scale (0–9), SCHW scores 7/9 vs MS's 6/9, reflecting strong financial health.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+21.3%+17.1%
ROA (TTM)Return on assets+2.1%+1.3%
ROICReturn on invested capital+9.9%+3.1%
ROCEReturn on capital employed+13.7%+3.3%
Piotroski ScoreFundamental quality 0–976
Debt / EquityFinancial leverage0.63x4.22x
Net DebtTotal debt minus cash-$15.1B$363.9B
Cash & Equiv.Liquid assets$46.0B$111.7B
Total DebtShort + long-term debt$31.0B$475.6B
Interest CoverageEBIT ÷ Interest expense4.23x0.50x
SCHW leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $19,920 today (with dividends reinvested), compared to $11,821 for SCHW. Over the past 12 months, MS leads with a +13.7% total return vs SCHW's -1.6%. The 3-year compound annual growth rate (CAGR) favors MS at 36.5% vs SCHW's 19.4% — a key indicator of consistent wealth creation.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
YTD ReturnYear-to-date-9.0%+2.1%
1-Year ReturnPast 12 months-1.6%+13.7%
3-Year ReturnCumulative with dividends+70.4%+154.4%
5-Year ReturnCumulative with dividends+18.2%+99.2%
10-Year ReturnCumulative with dividends+207.5%+518.8%
CAGR (3Y)Annualised 3-year return+19.4%+36.5%
MS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

SCHW leads this category, winning 2 of 2 comparable metrics.

SCHW is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than MS's 1.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5000.45x1.46x
52-Week HighHighest price in past year$114.53$232.25
52-Week LowLowest price in past year$83.96$152.80
% of 52W HighCurrent price vs 52-week peak+79.9%+78.1%
RSI (14)Momentum oscillator 0–10047.243.3
Avg Volume (50D)Average daily shares traded8.7M5.8M
SCHW leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

MS leads this category, winning 2 of 2 comparable metrics.

Wall Street rates SCHW as "Buy" and MS as "Buy". Consensus price targets imply 28.6% upside for SCHW (target: $118) vs 16.8% for MS (target: $212). For income investors, MS offers the higher dividend yield at 2.28% vs SCHW's 1.43%.

MetricSCHW logoSCHWThe Charles Schwa…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$117.63$212.00
# AnalystsCovering analysts5153
Dividend YieldAnnual dividend ÷ price+1.4%+2.3%
Dividend StreakConsecutive years of raises112
Dividend / ShareAnnual DPS$1.31$4.14
Buyback YieldShare repurchases ÷ mkt cap+6.2%+2.0%
MS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

SCHW leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MS leads in 3 (Valuation Metrics, Total Returns).

Best OverallThe Charles Schwab Corporat… (SCHW)Leads 3 of 6 categories

Custom Comparison: SCHW vs MS

Compare on any lens — Growth, Value, Income, or pick from 130+ individual metrics.

View as:

SCHW vs MS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is SCHW or MS a better buy right now?

For growth investors, The Charles Schwab Corporation (SCHW) is the stronger pick with 22.

0% revenue growth year-over-year, versus 14. 5% for Morgan Stanley (MS). Morgan Stanley (MS) offers the better valuation at 17. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate The Charles Schwab Corporation (SCHW) a "Buy" — based on 51 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SCHW or MS?

On trailing P/E, Morgan Stanley (MS) is the cheapest at 17.

8x versus The Charles Schwab Corporation at 19. 6x. On forward P/E, Morgan Stanley is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Charles Schwab Corporation wins at 0. 83x versus Morgan Stanley's 1. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — SCHW or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +99.

2%, compared to +18. 2% for The Charles Schwab Corporation (SCHW). Over 10 years, the gap is even starker: MS returned +518. 8% versus SCHW's +207. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SCHW or MS?

By beta (market sensitivity over 5 years), The Charles Schwab Corporation (SCHW) is the lower-risk stock at 0.

45β versus Morgan Stanley's 1. 46β — meaning MS is approximately 226% more volatile than SCHW relative to the S&P 500. On balance sheet safety, The Charles Schwab Corporation (SCHW) carries a lower debt/equity ratio of 63% versus 4% for Morgan Stanley — giving it more financial flexibility in a downturn.

05

Which is growing faster — SCHW or MS?

By revenue growth (latest reported year), The Charles Schwab Corporation (SCHW) is pulling ahead at 22.

0% versus 14. 5% for Morgan Stanley (MS). On earnings-per-share growth, the picture is similar: The Charles Schwab Corporation grew EPS 55. 9% year-over-year, compared to 28. 3% for Morgan Stanley. Over a 3-year CAGR, MS leads at 9. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SCHW or MS?

The Charles Schwab Corporation (SCHW) is the more profitable company, earning 37.

0% net margin versus 25. 6% for Morgan Stanley — meaning it keeps 37. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SCHW leads at 47. 9% versus 33. 3% for MS. At the gross margin level — before operating expenses — SCHW leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SCHW or MS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Charles Schwab Corporation (SCHW) is the more undervalued stock at a PEG of 0. 83x versus Morgan Stanley's 1. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Morgan Stanley (MS) trades at 14. 1x forward P/E versus 14. 2x for The Charles Schwab Corporation — 0. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SCHW: 28. 6% to $117. 63.

08

Which pays a better dividend — SCHW or MS?

All stocks in this comparison pay dividends.

Morgan Stanley (MS) offers the highest yield at 2. 3%, versus 1. 4% for The Charles Schwab Corporation (SCHW).

09

Is SCHW or MS better for a retirement portfolio?

For long-horizon retirement investors, The Charles Schwab Corporation (SCHW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

45), 1. 4% yield, +207. 5% 10Y return). Both have compounded well over 10 years (SCHW: +207. 5%, MS: +518. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SCHW and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SCHW is a mid-cap high-growth stock; MS is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Related Comparisons

Other popular comparisons that include one of these companies.

Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Side-by-side metric comparisons analyze public fundamental data for analytical evaluation. See our Terms of Service and Privacy Policy.